{"id":15895,"date":"2020-01-07T05:07:26","date_gmt":"2020-01-07T05:07:26","guid":{"rendered":"https:\/\/dev.curiumpharma.com\/2020\/01\/07\/announce-fda-filing-cu-64\/"},"modified":"2020-02-25T23:16:32","modified_gmt":"2020-02-25T23:16:32","slug":"fda-new-drug-filing-cu-64","status":"publish","type":"post","link":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/","title":{"rendered":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":65,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[91],"tags":[],"class_list":["post-15895","post","type-post","status-publish","format-standard","hentry","category-persberichten"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma<\/title>\n<meta name=\"description\" content=\"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma\" \/>\n<meta property=\"og:description\" content=\"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/\" \/>\n<meta property=\"og:site_name\" content=\"Curium Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-07T05:07:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-02-25T23:16:32+00:00\" \/>\n<meta name=\"author\" content=\"Lauren Haynes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lauren Haynes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/\"},\"author\":{\"name\":\"Lauren Haynes\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/9dfd1bf1b3e0c90cb6cc5575b80603ba\"},\"headline\":\"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application\",\"datePublished\":\"2020-01-07T05:07:26+00:00\",\"dateModified\":\"2020-02-25T23:16:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/\"},\"wordCount\":14,\"articleSection\":[\"Persberichten\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/\",\"name\":\"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\"},\"datePublished\":\"2020-01-07T05:07:26+00:00\",\"dateModified\":\"2020-02-25T23:16:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/9dfd1bf1b3e0c90cb6cc5575b80603ba\"},\"description\":\"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2020\\\/01\\\/07\\\/fda-new-drug-filing-cu-64\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/\",\"name\":\"Curium Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curiumpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/9dfd1bf1b3e0c90cb6cc5575b80603ba\",\"name\":\"Lauren Haynes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g\",\"caption\":\"Lauren Haynes\"},\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/author\\\/lauren-haynes03gmail-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma","description":"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/","og_locale":"nl_NL","og_type":"article","og_title":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma","og_description":"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.","og_url":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/","og_site_name":"Curium Pharma","article_published_time":"2020-01-07T05:07:26+00:00","article_modified_time":"2020-02-25T23:16:32+00:00","author":"Lauren Haynes","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Lauren Haynes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/#article","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/"},"author":{"name":"Lauren Haynes","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/9dfd1bf1b3e0c90cb6cc5575b80603ba"},"headline":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application","datePublished":"2020-01-07T05:07:26+00:00","dateModified":"2020-02-25T23:16:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/"},"wordCount":14,"articleSection":["Persberichten"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/","url":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/","name":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application - Curium Pharma","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/#website"},"datePublished":"2020-01-07T05:07:26+00:00","dateModified":"2020-02-25T23:16:32+00:00","author":{"@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/9dfd1bf1b3e0c90cb6cc5575b80603ba"},"description":"Curium and RadioMedix announce the filing of the New Drug Application for Copper Cu-64 Dotatate injection, an exciting new imaging agent for NET physicians.","breadcrumb":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.curiumpharma.com\/nl\/2020\/01\/07\/fda-new-drug-filing-cu-64\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curiumpharma.com\/nl\/"},{"@type":"ListItem","position":2,"name":"RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application"}]},{"@type":"WebSite","@id":"https:\/\/www.curiumpharma.com\/#website","url":"https:\/\/www.curiumpharma.com\/","name":"Curium Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curiumpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/9dfd1bf1b3e0c90cb6cc5575b80603ba","name":"Lauren Haynes","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a67a73bfdc11a26a099f3658725fa76f7e28daa31f6367899649c714fdda91?s=96&d=mm&r=g","caption":"Lauren Haynes"},"url":"https:\/\/www.curiumpharma.com\/nl\/author\/lauren-haynes03gmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts\/15895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/users\/65"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/comments?post=15895"}],"version-history":[{"count":0,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts\/15895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/media?parent=15895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/categories?post=15895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/tags?post=15895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}